http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 20 Jul 2026 19:38:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BillionToOne%2C+Inc.++++++++For%3A+Jul+16++Filed+by%3A+Johnson+Nancy+JoAnn/26790743.html si-local-file:///var/storage/secattach/20260720/26790743.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++BillionToOne%2C+Inc.++++++++For%3A+Jul+16++Filed+by%3A+Johnson+Nancy+JoAnn/26790743.html Mon, 20 Jul 2026 19:38:00 -0400 BLLN http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html <p>BillionToOne, Inc. (Nasdaq: BLLN) has appointed Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, the company announced July 20. He will lead medical strategy for the company's Northstar liquid biopsy portfolio.</p> <p>Dr. Dmitrovsky joins from the Frederick National Laboratory for Cancer Research, where he served as Laboratory Director and President of Leidos Biomedical Research. He previously served as Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center and as Professor and Chair of Pharmacology and Toxicology at Dartmouth's Geisel School of Medicine.</p> <p>He graduated magna cum laude in Biochemical Sciences from Harvard University and received his medical http://www.streetinsider.com/Management+Changes/BillionToOne+names+oncology+veteran+as+chief+medical+officer/26787796.html Mon, 20 Jul 2026 09:00:37 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/Press+Releases/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/PRNewswire/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/PRNewswire/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813 http://www.streetinsider.com/PRNewswire/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html <div class="xn-content"> <p class="prntac"><i>Renowned physician-scientist, former Director of <span>Frederick National Laboratory</span>, and one of the nation's most accomplished leaders in oncology joins BillionToOne to advance <location value="LU/us.ca.nortar" idsrc="xmltag.org" >Northstar's</location> role in guiding real treatment decisions</i></p><p><span class="legendSpanClass"><location value="LU/us.ca.menark" idsrc="xmltag.org" >MENLO PARK, Calif.</location></span>, <span class="legendSpanClass"><chron>July 20, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4734073-1&amp;h=1118261315&amp;u=https%3A%2F%2Fwww.billiontoone.com%2F&amp;a=BillionToOne" target="_blank" rel="nofollow">BillionToOne</a>, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the appointment of <person>Ethan Dmitrovsky</person>, MD, one of the most accomplished and influential physician leaders in oncology, as Chief Medical Officer, Oncology. <person>Dr. Dmitrovsky</person> will http://www.streetinsider.com/PRNewswire/BillionToOne+Appoints+Ethan+Dmitrovsky%2C+MD%2C+as+Chief+Medical+Officer%2C+Oncology%2C+to+Lead+Medical+Strategy+for+Northstar/26787773.html Mon, 20 Jul 2026 09:00:00 -0400 A.07880129 A.32727947 A.33662632 A.41702308 A.60001765 BLLN O.00048394 O.00081873 O.20228465 O.20738543 O.21200813